A DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECT OF VADADUSTAT ON THE PHARMACOKINETICS OF CELECOXIB, A CYP2C9 SUBSTRATE IN HEALTHY VOLUNTEERS

被引：0
|
作者：
Chandorkar, Gurudatt A. [1 ]
Farzaneh-Far, Ramin [2 ]
Buch, Akshay [1 ]
Maroni, Bradley [2 ]
机构：
[1] Akebia Therapeut, Clin Pharmacol, Cambridge, MA USA
[2] Akebia Therapeut, Med Res, Cambridge, MA USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP322
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [21] Study on the Effect of Three CYP2C9 Variants on Drug-Drug Interaction Related to Six Drugs In Vitro by LC-MS/MS Method
    Sun, Zhiping
    He, Lingli
    Yang, Qingqing
    Zhang, Haizhi
    Xu, Weiren
    Qin, Xinguang
    Liu, Gang
    Hu, Zhongze
    Zhang, Luyong
    Liu, Changxiao
    CHROMATOGRAPHIA, 2022, 85 (03) : 221 - 231
  • [22] DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF ELAGOLIX ON THE PHARMACOKINETICS OF OMEPRAZOLE IN HEALTHY PREMENOPAUSAL FEMALES.
    Nader, A.
    Mostafa, N.
    Ali, F.
    Shebley, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S66 - S66
  • [23] Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: Implication for clinical drug-drug interactions
    Song, Jin-Hui
    Sun, Dong-Xue
    Chen, Bin
    Ji, Dai-Hong
    Pu, Jie
    Xu, Jie
    Tian, Feng-De
    Guo, Lin
    JOURNAL OF BIOSCIENCES, 2011, 36 (05) : 879 - 885
  • [24] Drug-Drug Interaction Study of Apixaban with Cyclosporine and Tacrolimus in Healthy Volunteers
    Bashir, Babar
    Stickle, Douglas F.
    Chervoneva, Inna
    Kraft, Walter K.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (06): : 590 - 596
  • [25] DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECT OF STRONG CYP3A INHIBITION AND INDUCTION ON THE PHARMACOKINETICS OF AFICAMTEN, AND THE EFFECT OF AFICAMTEN ON P-GLYCOPROTEIN, IN HEALTHY PARTICIPANTS
    Xu, D.
    Lutz, J.
    Divanji, P.
    Cheplo, K.
    Li, J.
    Kupfer, S.
    German, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S85 - S85
  • [26] Population pharmacokinetic modelling of S-warfarin to evaluate the design of drug–drug interaction studies for CYP2C9
    Kerenaftali Klein
    Ivelina Gueorguieva
    Leon Aarons
    Journal of Pharmacokinetics and Pharmacodynamics, 2012, 39 : 147 - 160
  • [27] Phenoconversion Due to Drug-Drug Interactions in CYP2C19 Genotyped Healthy Volunteers
    Abouir, Kenza
    Exquis, Nadia
    Gloor, Yvonne
    Daali, Youssef
    Samer, Caroline Flora
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (04) : 1121 - 1129
  • [28] Pharmacokinetics, Safety, and Tolerability of Etrasimod: Results From a Phase 1 Drug-Drug Interaction Study in Healthy Volunteers
    Lee, Caroline A.
    Tang, Yong
    Villa-Caballero, Leonel
    Shan, Kevin
    Randle, Andrenika
    Grundy, John S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S550 - S550
  • [29] Investigating Effects of Cyclosporine on Eltrombopag Pharmacokinetics in Healthy Volunteers: A Phase 1 Crossover, Drug-Drug Interaction Study
    Zhang, Jianping
    Erickson-Miller, Connie L.
    Chan, Geoffrey
    Zhou, Yan Yan
    BLOOD, 2015, 126 (23)
  • [30] Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment
    Gschwind, Liliane
    Rollason, Victoria
    Boehlen, Francoise
    Rebsamen, Michela
    Combescure, Christophe
    Gruenenwald, Michele
    Matthey, Alain
    Bonnabry, Pascal
    Dayer, Pierre
    Desmeules, Jules Alexandre
    PHARMACOGENOMICS, 2013, 14 (07) : 745 - 753
12345